Front 242 to end live concerts after 40+ year career

    0
    14

    After an incredible 40-plus-year run on the road, Belgian EBM act Front 242 are setting an end to their live concert career, announcing their final performances to take place in the fall and winter of 2024-2025. The band makes the announcement today in conjunction with International EBM Day (noted as 24/2 in European territories).

    Front 242 to

    The concerts stretch across the globe, including a dozen dates in the U.S. beginning September 6 in Tampa, Florida and running through November 15 and 16 in the band’s second home in Chicago. The band’s final performances will be in their hometown of Brussels, Belgium in January 2025.

    “It is with a heavy mix of emotion that we close this great adventure, some 40 years in the making,” say Patrick, Richard and Lean Juc, the band’s core members. “We realize that ending our journey at this time, when we are still vibrant and full of energy is how the band should be remembered. We are excited to share these meaningful final performances with our wonderful fans who have been with us through it all.”

    All tickets will go on sale Friday March 1. Find more information at www.front242.com.

    FRONT 242 FINAL U.S. DATES

    US Dates:

    September 06            Tampa, FL                  Jannus Landing

    September 07            Philadelphia, PA       Union Transfer

    September 08            Cleveland, OH           Agora Theater

    September 13            Los Angeles, CA       The Mayan

    September 14            Portland, OR              Roseland

    September 15            San Francisco, CA    Great American Music Hall

    November 08             Houston, TX              Rise Rooftop

    November 09             Dallas, TX                  Granada Theater

    November 10             Denver, CO                Reelworks

    November 15             Chicago, IL                Metro

    November 16             Chicago, IL                Metro

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here